This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Theodorescu, D. Articles by Frierson, H. F. Search for Related Content PubMed PubMed Citation Articles by Theodorescu, D. Articles by Frierson, H. F., Jr.

Reduced Expression of Metastasis Suppressor RhoGDI2 Is Associated with Decreased Survival for Patients with Bladder Cancer

¹ Department of Molecular Physiology and Biological Physics, University of Virginia Health Sciences Center, Charlottesville, Virginia; ² Genomics Institute of the Novartis Research Foundation, San Diego, California; and Departments of ³ Health Evaluation Sciences (Biostatistics) and ⁴ Pathology, University of Virginia Health Sciences Center, Charlottesville, Virginia

Purpose: RhoGDI2 was recently shown to be a metastasis suppressor gene in models of bladder cancer. We sought to further understand its importance in human cancer by determining the level of its expression and the distribution of its encoded protein in normal human tissues and cell lines and to evaluate whether its protein expression is a determinant of human bladder cancer progression.

Experimental Design: RhoGDI2 mRNA and protein expression was evaluated in cell lines and human tissues using Affymetrix and tissue microarrays, respectively. Tissue microarrays represented most human normal adult tissues and material from 51 patients that had undergone radical cystectomy for bladder cancer. In these 51 patients, the ² test was used to test for associations between RhoGDI2 and stage, grade of urothelial carcinoma, histological type, and disease-specific survival status. Cox proportional hazards regression analyses were used to estimate the effect of RhoGDI2 expression level on time to development of metastatic disease and disease-specific survival time, adjusting for grade, stage, and histological type.

Results: In normal tissues, there was strong RhoGDI2 protein expression in WBCs, endothelial cells, and transitional epithelium. RhoGDI2 mRNA expression was inversely related to the invasive and metastatic phenotype in human bladder cancer cell lines. In patients with bladder cancer, univariate analysis indicated that reduced tumor RhoGDI2 protein expression was associated with a lower actuarial 5-year disease-free and disease-specific survival (P = 0.01). In addition, patients with tumors that had low or absent RhoGDI2 had a shorter time to disease-specific death (P 0.01). When tumor grade, stage, histological type, and RhoGDI2 staining level were examined using multivariate analysis, RhoGDI2 expression was found to be an independent predictive factor for disease-specific death (P = 0.03).

Conclusions: These results suggest that RhoGDI2 is an independent predictor of prognosis for patients with bladder cancer and provide clinical evidence in support of its involvement in cancer metastasis.

This article has been cited by other articles:

				Y. Zhang, L. A. R. Rosado, S. Y. Moon, and B. Zhang Silencing of D4-GDI Inhibits Growth and Invasive Behavior in MDA-MB-231 Cells by Activation of Rac-dependent p38 and JNK Signaling J. Biol. Chem., May 8, 2009; 284(19): 12956 - 12965. [Abstract] [Full Text] [PDF]

				H. J. Cho, K. E. Baek, S.-M. Park, I.-K. Kim, Y.-L. Choi, H.-J. Cho, I.-K. Nam, E. M. Hwang, J.-Y. Park, J. Y. Han, et al. RhoGDI2 Expression Is Associated with Tumor Growth and Malignant Progression of Gastric Cancer Clin. Cancer Res., April 15, 2009; 15(8): 2612 - 2619. [Abstract] [Full Text] [PDF]

				Y. Wu, K. Moissoglu, H. Wang, X. Wang, H. F. Frierson, M. A. Schwartz, and D. Theodorescu Src phosphorylation of RhoGDI2 regulates its metastasis suppressor function PNAS, April 7, 2009; 106(14): 5807 - 5812. [Abstract] [Full Text] [PDF]

				K. Moissoglu, K. S. McRoberts, J. A. Meier, D. Theodorescu, and M. A. Schwartz Rho GDP Dissociation Inhibitor 2 Suppresses Metastasis via Unconventional Regulation of RhoGTPases Cancer Res., April 1, 2009; 69(7): 2838 - 2844. [Abstract] [Full Text] [PDF]

				Y.-C. Chao, S.-H. Pan, S.-C. Yang, S.-L. Yu, T.-F. Che, C.-W. Lin, M.-S. Tsai, G.-C. Chang, C.-H. Wu, Y.-Y. Wu, et al. Claudin-1 Is a Metastasis Suppressor and Correlates with Clinical Outcome in Lung Adenocarcinoma Am. J. Respir. Crit. Care Med., January 15, 2009; 179(2): 123 - 133. [Abstract] [Full Text] [PDF]

				D. Schunke, P. Span, H. Ronneburg, A. Dittmer, M. Vetter, H.-J. Holzhausen, E. Kantelhardt, S. Krenkel, V. Muller, F. C.G.J. Sweep, et al. Cyclooxygenase-2 Is a Target Gene of Rho GDP Dissociation Inhibitor {beta} in Breast Cancer Cells Cancer Res., November 15, 2007; 67(22): 10694 - 10702. [Abstract] [Full Text] [PDF]

				C. W. Rinker-Schaeffer, J. P. O'Keefe, D. R. Welch, and D. Theodorescu Metastasis Suppressor Proteins: Discovery, Molecular Mechanisms, and Clinical Application. Clin. Cancer Res., July 1, 2006; 12(13): 3882 - 3889. [Full Text] [PDF]

				Y. Zhang and B. Zhang D4-GDI, a Rho GTPase Regulator, Promotes Breast Cancer Cell Invasiveness Cancer Res., June 1, 2006; 66(11): 5592 - 5598. [Abstract] [Full Text] [PDF]

				S. C. Smith, G. Oxford, Z. Wu, M. D. Nitz, M. Conaway, H. F. Frierson, G. Hampton, and D. Theodorescu The Metastasis-Associated Gene CD24 Is Regulated by Ral GTPase and Is a Mediator of Cell Proliferation and Survival in Human Cancer Cancer Res., February 15, 2006; 66(4): 1917 - 1922. [Abstract] [Full Text] [PDF]

				G. Oxford, C. R. Owens, B. J. Titus, T. L. Foreman, M. C. Herlevsen, S. C. Smith, and D. Theodorescu RalA and RalB: Antagonistic Relatives in Cancer Cell Migration Cancer Res., August 15, 2005; 65(16): 7111 - 7120. [Abstract] [Full Text] [PDF]

				B. Titus, H. F. Frierson Jr., M. Conaway, K. Ching, T. Guise, J. Chirgwin, G. Hampton, and D. Theodorescu Endothelin Axis Is a Target of the Lung Metastasis Suppressor Gene RhoGDI2 Cancer Res., August 15, 2005; 65(16): 7320 - 7327. [Abstract] [Full Text] [PDF]